FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a key

Company profile

Zenas BioPharma, Inc. Insider Trading

ZBIO

Every SEC Form 4 insider trading filing for Zenas BioPharma, Inc. (ZBIO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001953926
Filings
65
Insiders
22
Last filing
2026-09-01
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Christy J. Oliger.

Three year balance

Buy and sell value by quarter, Q3 24 to Q3 26. Zenas BioPharma, Inc. insiders are net buyers across the period shown.

PurchasesSales
$82.9MQ3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $82.9M.

90 day insight

Over the last 90 days, Zenas BioPharma, Inc. insiders bought $0 across 1 transaction with no open-market sales.

  • Most active insider: Christy J. Oliger with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Sep 1, 2026Christy J. OligerZBIO
Award
37,000——-6.1% 1w
Jun 15, 2026Hongbo LuZBIO
Award
18,500——+72.1% 3m
Jun 15, 2026Moltke Lisa vonZBIO
Award
150,000——+72.1% 3m
Jun 15, 2026James P BoylanZBIO
Award
18,500——+72.1% 3m
Jun 15, 2026Patricia L AllenZBIO
Award
18,500——+72.1% 3m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=ZBIO" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Fairmount Funds Management LLC2 filings+$9.0M
Hongbo LuDirector4 filings+$7.2M
Leon O Moulder JrSee Remarks10 filings+$6.5M
SR ONE CAPITAL MANAGEMENT, LLC10% owner2 filings+$2.4M
Patrick G EnrightDirector2 filings+$2.3M

Institutional Ownership

Top 13F-HR holders of Zenas BioPharma, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$189.3M
QoQ change
-82.5%
Reporting period
2026-06-30
#1
State Street Corp
CIK 0000093751
$52.2M
2.1M shares
#2
Nvp Associates, LLC
CIK 0001545692
$46.7M
1.8M shares
#3
BlackRock, Inc.
CIK 0002012383
$36.2M
1.4M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/